Zubair Shah is a Cardiology physician affiliated with University of Kansas Medical Center. OpenAlex indexes 175 publications with 4,800 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge St Ste G600
Kansas City, KS 661608501
Telephone
913-588-9600Provider last certified this registry record 8 Jul 2021.
Clinical trials
- Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population
Sponsor: University of Kansas Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year202558 payments$47,831openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20255 payments$34,165openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202540 payments$22,828openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.8%Beta blocker11%Metoprolol Succinate51%Carvedilol38%Metoprolol Tartrate10%Bisoprolol Fumarate3%Part D<11 patientsAldosterone antagonist (MRA)10%Spironolactone92%Eplerenone8%Part D≥240 patients+ 16 more classes in this area
Metabolism & gastrointestinal
17.7%SGLT2 inhibitor8.5%Jardiance54%Farxiga46%Part D≥111 patientsPotassium supplement3.5%Potassium Chloride90%Klor-Con M2010%Part D≥93 patients+ 5 more classes in this area
Nervous system
15.2%Other nervous system drugs13%Vyndamax100%Part D≥110 patientsSSRI0.9%Trazodone Hcl70%Sertraline Hcl30%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep learning for surgical instrument recognition and segmentation in robotic-assisted surgeries: a systematic review
Artificial Intelligence Review
2024 - Genetic biomarkers and machine learning techniques for predicting diabetes: systematic review
Artificial Intelligence Review
2024 - Applications of Artificial Intelligence (AI) in Medical Education: A Scoping Review
Studies in health technology and informatics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”